Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 3, 2013, Pages 507-514

  Morisaki, Akimasa ^a   Nakahira, Atsushi ^a   Sasaki, Yasuyuki ^a   Hirai, Hidekazu ^a   Okada, Yuko ^a   Suehiro, Shigefumi ^a   Shibata, Toshihiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood coagulation; Extracorporeal circulation; Fibrinolysis; Valve diseases

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; FIBRINOGEN DEGRADATION PRODUCT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; THROMBIN ANTITHROMBIN III COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CARDIOTOMY SUCTION; CARDIOVASCULAR SURGICAL EQUIPMENT; CLINICAL ARTICLE; CONTINUOUS AUTOTRANSFUSION SYSTEM; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; FEMALE; FIBRINOLYSIS; HEART HEMODYNAMICS; HEMATOCRIT; HUMAN; INFLAMMATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE COUNT;

BLOOD COAGULATION; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; VALVE DISEASES;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; OPERATIVE BLOOD SALVAGE; PROSPECTIVE STUDIES; SUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882748439     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt241     Document Type: Article

References (25)

1. Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR, DeFoe GR et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006;132:283-90
2. De Somer F, Van Belleghem Y, Caes F, Francois K, Van Overbeke H, Arnout J et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;123:951-8
3. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004;78:54-9
4. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 2007;116:1888-95
5. Belway D, Rubens FD, Wozny D, Henley B, Nathan HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion 2005;20:237-41
6. Puehler T, Haneya A, Philipp A, Zausig YA, Kobuch R, Diez C et al. Minimized extracorporeal circulation system in coronary artery bypass surgery: A 10-year single-center experience with 2243 patients. Eur J Cardiothorac Surg 2011;39:459-64
7. Nilsson J, Scicluna S, Malmkvist G, Pierre L, Algotsson L, Paulsson P et al. A randomized study of coronary artery bypass surgery performed with the Resting Heart System utilizing a low vs a standard dosage of heparin. Interact CardioVasc Thorac Surg 2012;15:834-9
8. Castiglioni A, Verzini A, Colangelo N, Nascimbene S, Laino G, Alfieri O. Comparison of minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement: A randomized study. Interact CardioVasc Thorac Surg 2009;9:37-41; discussion 41
9. Yilmaz A, Sjatskig J, van Boven WJ, Waanders FG, Kelder JC, Sonker U et al. Combined coronary artery bypass grafting and aortic valve replacement with minimal extracorporeal closed circuit circulation versus standard cardiopulmonary bypass. Interact CardioVasc Thorac Surg 2010;11:754-7
10. Yuruk K, Bezemer R, Euser M, Milstein DM, de Geus HH, Scholten EW et al. The effects of conventional extracorporeal circulation versus miniaturized extracorporeal circulation on microcirculation during cardiopulmonary bypass-assisted coronary artery bypass graft surgery. Interact CardioVasc Thorac Surg 2012;15:364-70
11. Nakahira A, Sasaki Y, Hirai H, Fukui T, Matsuo M, Takahashi Y et al. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting. Interact CardioVasc Thorac Surg 2010;10: 555-60
12. Nakahira A, Sasaki Y, Hirai H, Matsuo M, Morisaki A, Suehiro S et al. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery. J Thorac Cardiovasc Surg 2011;141:1289-97
13. Jenni H, Rheinberger J, Czerny M, Gygax E, Rieben R, Krahenbuhl E et al. Autotransfusion system or integrated automatic suction device in minimized extracorporeal circulation: Influence on coagulation and inflammatory response. Eur J Cardiothorac Surg 2011;39:e139-43
14. Jewell AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg 2003;23:633-6
15. Dai B, Wang L, Djaiani G, Mazer CD. Continuous and discontinuous cellwashing autotransfusion systems. J Cardiothorac Vasc Anesth 2004;18: 210-17
16. Vermeijden WJ, Hagenaars A, van Oeveren W, de Vries AJ. Do repeated runs of a cell saver device increase the pro-inflammatory properties of washed blood? Eur J Cardiothorac Surg 2008;34:350-53
17. Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002;22:527-33
18. Bical OM, Fromes Y, Gaillard D, Fischer M, Ponzio O, Deleuze P et al. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. Eur J Cardiothorac Surg 2006; 29:699-702
19. Hammon JW. Extracorporeal circulation: The response of humoral and cellular elements of blood to extracorporeal circulation. In: Cohn LH (ed Cardiac Surgery in the Adult, 3rd ed. New York: McGraw-Hill, 2007, 370-89
20. Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparincoated surface. J Thorac Cardiovasc Surg 2002;124:321-32
21. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993;82:3350-57
22. Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials. Anesth Analg 2009;109:320-30
23. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: A randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 2007;116:I89-97
24. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg 2003; 125:1438-50
25. Fabre O, Vincentelli A, Corseaux D, Juthier F, Susen S, Bauters A et al. Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg 2008;86:537-41